C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2011
11/16/2011	CN101062944B Vegetable disease-resistant protein and its coding gene and application
11/16/2011	CN101012454B Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
11/15/2011	US8058515 Plant cells and plants overexpressing vacuolar proton pyrophosphatases
11/15/2011	US8058512 Gene expression and production of TGF-β proteins including bioactive mullerian inhibiting substance from plants
11/15/2011	US8058511 Expression vector for use as tool in transfer of exogenous genes into cells
11/15/2011	US8058508 Optimizing glycan processing in plants
11/15/2011	US8058442 Neuroprotective iron chelators and pharmaceutical compositions comprising them
11/15/2011	US8058421 Promoters for regulation of gene expression in plant roots
11/15/2011	US8058420 Promoters for regulation of gene expression in plant roots
11/15/2011	US8058419 Promoters for regulation of gene expression in plant roots
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058408 Transcription factor having zinc finger domains
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058397 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
11/15/2011	US8058396 Cystatin C as an antagonist of TGF-β and methods related thereto
11/15/2011	US8058395 Chimeric protein comprising a green fluorescent ptotein fused to a transcription factor
11/15/2011	US8058391 Process for the preparation of insulin conjugate IN-105
11/15/2011	US8058390 HDM2-inhibitor complexes and uses thereof
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058242 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule
11/15/2011	US8058241 Signal transduction protein TAB2
11/15/2011	US8058237 Stable composition of GDF-5 and method of storage
11/15/2011	US8058236 Aqueous inhalation pharmaceutical composition
11/15/2011	US8058233 Modification of feeding behavior using PYY and GLP-1
11/15/2011	US8058232 HMGB1 high affinity binding domain Box-A mutants
11/15/2011	US8058231 Transcriptional regulation of high affinity IgE receptor γ-chain
11/15/2011	US8058229 Method of increasing red blood cell levels or treating anemia in a patient
11/15/2011	US8058228 Leptin peptide antagonists
11/15/2011	US8058225 Proteins for use in human and animal Staphylococcus infections
11/15/2011	US8058068 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
11/15/2011	US8058061 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/15/2011	US8058050 Cellular permissivity factor for viruses and uses thereof
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8058047 α-galactosidase with transgalactosylating activity
11/15/2011	US8058038 Aldolase and production process of substituted α-keto acids
11/15/2011	US8058017 Methods and compositions for purifying human factor VIII, factor VIII-like proteins or fragments thereof
11/15/2011	US8058012 Five-helix protein
11/15/2011	US8057996 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
11/15/2011	US8057990 Prevent, therapy for cancer; complex of tacrine compound and protein
11/15/2011	US8057822 Modified exendins and exendin agonists
11/15/2011	US8057806 Viruses comprising mutant ion channel protein
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	US8057802 Treatment methods for fibrosis related disorders
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057787 Protease resistant modified interferon-beta polypeptides
11/15/2011	US8057162 vaccination directed against the hepatitis C virus (HCV);
11/15/2011	US8056719 Multipurpose packages for sterile products or products to be sterilized
11/15/2011	CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011	CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011	CA2417871C Enhanced 2-keto-l-gulonic acid production
11/15/2011	CA2405715C Methods for selective targeting
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2395897C Insecticidal proteins from bacillus thuringiensis
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011	CA2372655C Recombinant adenovirus having low pre-existing neutralizing activity
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2296005C Tenebrio antifreeze proteins
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2252970C Optimization of cells for endogenous gene activation
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/12/2011	CA2740237A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/10/2011	WO2011140441A2 Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
11/10/2011	WO2011140397A2 Stem cell defined media for xeno-free and feeder free conditions and uses thereof
11/10/2011	WO2011140391A2 Egfr-related polypeptides and methods of use
11/10/2011	WO2011140267A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	WO2011140135A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
11/10/2011	WO2011140132A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
11/10/2011	WO2011140092A1 Bifunctional molecules for inactivating hiv and blocking hiv
11/10/2011	WO2011140086A2 Serum albumin binding molecules
11/10/2011	WO2011139994A2 Genetic elements, proteins, and associated methods including application of additional genetic information to gram (+) thermoacidophiles
11/10/2011	WO2011139769A2 Immunogenic compositions and methods for treating neoplasia
11/10/2011	WO2011139672A1 Antimicrobial bacteria strains and uses thereof
11/10/2011	WO2011139629A2 Light targeting molecules and uses thereof
11/10/2011	WO2011139385A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins
11/10/2011	WO2011139370A1 Therapeutic peptide composition and method
11/10/2011	WO2011139228A1 Nano scale collagen particles and membranes
11/10/2011	WO2011139226A1 Compounds, medicaments and methods of treatment for helicobacter pylori infection.
11/10/2011	WO2011138802A1 Injection solution
11/10/2011	WO2011138671A2 Tubby-like protein isoforms and their applications
11/10/2011	WO2011138641A1 A construct comprising a ni and/or au substrate
11/10/2011	WO2011138593A1 Engineered e2 for increasing the content of free lys11- linked ubiquitin
11/10/2011	WO2011138586A1 Dengue virus vaccine
11/10/2011	WO2011138512A1 Sulphated hyaluronic acid in combination with g-csf for use in mobilising blood stem cells
11/10/2011	WO2011138506A1 Flow cytometric method for distinguishing between bacterial and viral infections
11/10/2011	WO2011138489A1 Use of casein hydrolysates as antiviral agents
11/10/2011	WO2011138449A2 Antagonists of sema3e/plexind1 interaction as anti-cancer agents
11/10/2011	WO2011138423A1 Chimeric receptors and methods for identifying agents exhibiting an activity on type 1 single pass transmembrane receptors
11/10/2011	WO2011138414A1 Methods and tools for screening agents exhibiting an activity on receptors of the tumor necrosis factor receptor superfamily
11/10/2011	WO2011138251A1 Lentiviral vector based immunological compounds against malaria
11/10/2011	WO2011138032A2 Universal influenza vaccines and methods for their generation
11/10/2011	WO2011137998A1 Brassica plants with altered architecture
11/10/2011	WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof

1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 2916